ES2311459T3 - Diagnostico de restenosis. - Google Patents

Diagnostico de restenosis. Download PDF

Info

Publication number
ES2311459T3
ES2311459T3 ES00937731T ES00937731T ES2311459T3 ES 2311459 T3 ES2311459 T3 ES 2311459T3 ES 00937731 T ES00937731 T ES 00937731T ES 00937731 T ES00937731 T ES 00937731T ES 2311459 T3 ES2311459 T3 ES 2311459T3
Authority
ES
Spain
Prior art keywords
restenosis
diagnosis
predisposed
kits
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00937731T
Other languages
English (en)
Inventor
Kenneth S Kornman
Gordon W Duff
David C Crossman
Sheila E Francis
Katherine Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interleukin Genetics Inc
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/431,352 external-priority patent/US6524795B1/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of ES2311459T3 publication Critical patent/ES2311459T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sorption Type Refrigeration Machines (AREA)

Abstract

Un método para determinar si un sujeto presenta o tiene predisposición a desarrollar una reestenosis arterial, que comprende detectar un alelo de IL-1RN(VNTR) en una muestra de ácido nucleico procedente de ese sujeto, en el que la detección del alelo 2 de IL-1RN(VNTR) asociado a reestenosis indica que ese sujeto no tiene predisposición a desarrollar reestenosis.
ES00937731T 1999-05-24 2000-05-24 Diagnostico de restenosis. Expired - Lifetime ES2311459T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31767499A 1999-05-24 1999-05-24
US09/431,352 US6524795B1 (en) 1997-03-10 1999-11-01 Diagnostics for cardiovascular disorders

Publications (1)

Publication Number Publication Date
ES2311459T3 true ES2311459T3 (es) 2009-02-16

Family

ID=26981080

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00937731T Expired - Lifetime ES2311459T3 (es) 1999-05-24 2000-05-24 Diagnostico de restenosis.

Country Status (8)

Country Link
EP (1) EP1192277B1 (es)
JP (1) JP2003500069A (es)
AT (1) ATE403746T1 (es)
AU (1) AU782836B2 (es)
CA (1) CA2374531A1 (es)
DE (1) DE60039760D1 (es)
ES (1) ES2311459T3 (es)
WO (1) WO2000071753A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820383B2 (en) 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US7306913B2 (en) * 2002-12-20 2007-12-11 Applera Corporation Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
EP1613774A2 (en) 2003-03-10 2006-01-11 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
US20040224893A1 (en) * 2003-05-06 2004-11-11 Li-Hsien Wang Methods of using IL-1 antagonists to treat neointimal hyperplasia
JP2009523006A (ja) * 2004-05-07 2009-06-18 アプレラ コーポレイション 脈管疾患に関連する遺伝的多型、その検出方法および使用
US9668969B1 (en) 2012-02-22 2017-06-06 Arturo Solis Herrera Methods of using QIAPINE
JP6460993B2 (ja) * 2012-10-04 2019-01-30 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 血管疾患及びその合併症の処置
RU2740444C1 (ru) * 2020-07-17 2021-01-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития тромботических осложнений после реконструктивно-восстановительных вмешательств на магистральных артериях нижних конечностей
CN116889630B (zh) * 2023-08-22 2025-08-26 温州医科大学 Pai-1抑制剂在制备肝脏缺血再灌注损伤治疗药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820383B2 (en) 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction

Also Published As

Publication number Publication date
EP1192277A2 (en) 2002-04-03
AU5286700A (en) 2000-12-12
ATE403746T1 (de) 2008-08-15
WO2000071753A3 (en) 2002-02-07
DE60039760D1 (de) 2008-09-18
WO2000071753A2 (en) 2000-11-30
AU782836B2 (en) 2005-09-01
EP1192277B1 (en) 2008-08-06
JP2003500069A (ja) 2003-01-07
CA2374531A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
ATE339196T1 (de) Zelladhäsionsinhibitoren
TR199902516T2 (xx) Kalsilitik bile�imleri.
FI973596L (fi) Lähteen puheaktiviteetin tunnistus
DE60044114D1 (de) Wegwerfartikel zum Aufnehmen von Urin für den Mann
EP0745843A3 (en) Electrochemical immunobiosensor
EP1036320A4 (en) ENHANCED REACTIVE ELECTROCHEMICAL BIODETECTION STRIPS
DE69711244D1 (de) Verschlüsse für absorbierende kleidungsstücke
NO20010797L (no) Enzym-batteri
BR9607193B1 (pt) teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos.
EA199700061A1 (ru) Способ получения силденафила
HN1997000099A (es) Inhibidores de metaloproteasas matriciales basados en
DE69938196D1 (de) Acryl-terpolymer für die verwendung als selbstfixierendes klebmittel
WO2001000880A3 (en) Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
FI973115A7 (fi) Pariston kunnon testauslaite
IL142438A0 (en) Diagnostic and therapeutics for sepsis
ES2311459T3 (es) Diagnostico de restenosis.
DE59805687D1 (de) Fell für Schlaginstrument
ID26451A (id) Panel lapisan sekali pakai buang
EA200200435A1 (ru) Анализ лептина
ATE271225T1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
DE59903984D1 (de) Toilette
ATE496140T1 (de) Methoden und sondensätze zur bestimmung einer prognose von prostatakrebs
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ES2191962T3 (es) Procedimiento para la obtencion de metalocenos.
EP0969542A4 (en) BATTERY